VTE prevention in major orthopedic surgery.
Fishmann
Andrew
A
D000925:Anticoagulants / Q000627:therapeutic use; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects*; D001241:Aspirin / Q000627:therapeutic use; D017984:Enoxaparin / Q000627:therapeutic use; D000077425:Fondaparinux; D006801:Humans; D009985:Orthopedics; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011134:Polysaccharides / Q000627:therapeutic use; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D017984:Enoxaparin; D010975:Platelet Aggregation Inhibitors; D011134:Polysaccharides; D000077425:Fondaparinux; D001241:Aspirin